Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease WORLD JOURNAL OF GASTROENTEROLOGY Triadafilopoulos, G. 2014; 20 (24): 7730-7738

Abstract

One potential option for the management of refractory gastro-esophageal reflux disease (GERD) is the delivery of radiofrequency energy to the gastro-esophageal junction (Stretta). This endoscopic therapy is safe, effective, durable, and repeatable if necessary and serves an unmet need for many GERD sufferers. Stretta could be effective in decreasing esophageal sensitivity to acid and in decreasing the gastro-esophageal junction compliance, which in turn contributes to symptomatic benefit by decreasing refluxate volume. Therefore, Stretta may serve as an endoscopic pain modulator and should be considered in patients with refractory symptoms despite proton pump inhibitors, as well as in patients with functional heartburn.

View details for DOI 10.3748/wjg.v20.i24.7730

View details for Web of Science ID 000338520100018

View details for PubMedID 24976710

View details for PubMedCentralID PMC4069301